NCT04228289View on ClinicalTrials.gov

Oxytocin to Treat PTSD

PHASE2CompletedINTERVENTIONAL
Enrollment

185

Participants

Timeline

Start Date

November 16, 2020

Primary Completion Date

February 28, 2025

Study Completion Date

August 31, 2025

Conditions
PTSD
Interventions
DRUG

Oxytocin

40 IU intranasal spray

OTHER

Placebo

matching intranasal spray

Trial Locations (2)

94121

San Francisco VA Medical Center, San Francisco, CA, San Francisco

29401-5703

Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston

All Listed Sponsors
collaborator

San Francisco VA Health Care System

FED

lead

VA Office of Research and Development

FED

NCT04228289 - Oxytocin to Treat PTSD | Biotech Hunter | Biotech Hunter